Page last updated: 2024-09-04

pomalidomide and Leukemia, Plasmacytic

pomalidomide has been researched along with Leukemia, Plasmacytic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abe, O; Ikemura, M; Kurokawa, M; Maki, H; Masamoto, Y; Miwa, A; Morita, K; Nakazaki-Watadani, K; Obo, T; Sumida, Y; Takami, H; Takayanagi, S; Tanaka, S; Yasaka, K1
Coppi, MR; Guaragna, G; Mele, G; Melpignano, A; Spina, A1

Reviews

1 review(s) available for pomalidomide and Leukemia, Plasmacytic

ArticleYear
Isolated relapse of plasma cell leukemia in the central nervous systems: a case report and literature review.
    International journal of hematology, 2023, Volume: 118, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Plasma Cell; Multiple Myeloma; Recurrence

2023

Other Studies

1 other study(ies) available for pomalidomide and Leukemia, Plasmacytic

ArticleYear
Response to pomalidomide plus fixed low-dose dexamethasone in a case of secondary plasma cell leukaemia.
    Leukemia research, 2016, Volume: 40

    Topics: Aged; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Plasma Cell; Thalidomide; Treatment Outcome

2016